CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)	12 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Cash flows from operating activities:
Net loss	$ (12,029,786)	$ (10,420,885)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	240,892	123,685
Stock based compensation	1,051,898	750,621
Loss of dissolution of subsidiary	142,121	0
Accretion of right-of-use lease asset	24,408	30,532
Changes in operating assets and liabilities:
Accounts receivable	127,965	21,117
Prepaid expenses and other current assets	398,169	(636,688)
Accounts payable and other current liabilities	(174,727)	97,541
Deferred revenue	(344,547)	229,698
Due to related parties	58,479	37,222
Net cash used in operating activities	(10,505,128)	(9,767,157)
Cash flows from investing activities:
Purchases of property and equipment	(943,109)	(349,193)
Net cash used in investing activities	(943,109)	(349,193)
Cash flows from financing activities:
Tax withholding payments or tax equivalent payments for net share settlement of restricted stock units	(12,493)	(88,118)
Net proceeds from the issuance of common stock and exercise of warrants	8,927,211	17,456,092
Net cash provided by financing activities	8,914,718	17,367,974
Effect of Exchange Rate on Changes on Cash	(5,957)	0
Net (decrease) increase in cash and restricted cash	(2,533,519)	7,251,624
Cash and restricted cash at beginning of year	17,159,925	9,908,301
Cash and restricted cash	14,620,449	17,159,925
Supplemental information of non-cash investing and financing activities:
Issuances of common stock under cashless warrant exercises	0	676
Initial recognition of right-of-use lease asset and lease liability	625,471	744,430
Issuance of shares under vested restricted stock units, net stock option exercises and unvested share issuance for services	92	44
Reconciliation of cash, cash equivalents and restricted cash to the consolidated balance sheets:
Cash and cash equivalents	14,532,943	17,072,419
Restricted cash	$ 87,506	$ 87,506